Results 101 to 110 of about 3,663 (172)

Systemic lipid and glucose modulation differentially affects cognitive function and neuroinflammation in a mouse model of Alzheimer's disease. [PDF]

Front Neurosci
Kynigopoulos D, Fella E, Shahabian L, Christodoulou CC, Papacharalampous R, Diskos K, Vagiaki LE, Sidiropoulou K, Pipis M, Kleopa KA, Panayiotou E.   +10 more
europepmc   +1 more source

PCSK9 inhibitors: a promising lipid-lowering strategy for kidney transplant recipients. [PDF]

Ren Fail
Luo B, Guo L, Di W.
europepmc   +1 more source

Efficacy and safety of PCSK-9 inhibitors in patients with acute coronary syndrome: a systematic review and network meta-analysis. [PDF]

BMC Cardiovasc Disord
Kao G, Chen C, Zhang Y, Xu Y, Xu G.
europepmc   +1 more source

Hypercholesterolemia Successfully Treated With Two Different PCSK9 Inhibitors in a Patient With Glycogen Storage Disease IXd: Phosphorylase Kinase Deficiency. [PDF]

J Lipid Atheroscler
Huynh T, Nguyen H, Nguyen M.
europepmc   +1 more source

[Lipids - Diagnostics and treatment in diabetes mellitus (Update 2026)]. [PDF]

Wien Klin Wochenschr
Wascher TC, Paulweber B, Toplak H, Saely CH, Drexel H, Föger B, Hoppichler F, Stulnig T, Stingl H, Höllerl F, Clodi M.   +10 more
europepmc   +1 more source

Efficacy and safety of different proprotein convertase subtilisin/kexin type 9 inhibitors in the general population and solid organ transplant recipients: a network meta-analysis. [PDF]

Front Pharmacol
Luo B, Sun Z, Luo H.
europepmc   +1 more source

Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy. [PDF]

Arterioscler Thromb Vasc Biol
Reijnders E, Bossuyt PM, Jukema JW, Ruhaak LR, Romijn FPHTM, Szarek M, Trompet S, Bhatt DL, Bittner VA, Diaz R, Fazio S, Stevanovic I, Goodman SG, Harrington RA, White HD, Steg PG, Schwartz GG, Cobbaert CM.   +17 more
europepmc   +1 more source

Lipid lowering in coronary artery disease - not just statins. [PDF]

Clin Med (Lond)
Han J, Masmanian E, Wang T, Chua TP.
europepmc   +1 more source

Modulation of atherogenesis biomarkers by PCSK9 inhibitors in Lp(a)-stimulated human coronary artery endothelial cells. [PDF]

BMC Cardiovasc Disord
Zulkapli R, Muid SA, Wang SM, Putera Mohd Yusof MY, Nawawi H.   +4 more
europepmc   +1 more source

Impact of alirocumab on neoatherosclerosis formation and vessel healing after drug-eluting stent implantation in patients with acute myocardial infarction: a substudy of the PACMAN-AMI trial. [PDF]

Int J Cardiovasc Imaging
Kakizaki R, Ueki Y, Koskinas KC, Shibutani H, Losdat S, Biccirè FG, Otsuka T, Häner JD, Lønborg J, Kaiser C, Iglesias JF, Ondracek AS, Spirk D, Siontis GCM, Daemen J, Engstrøm T, Lang IM, Räber L.   +17 more
europepmc   +1 more source